Xiao Ping Ye
Chairman at Hunan Tiger-Xiangya R&D Co., Ltd.
Profile
Xiao Ping Ye is the founder of Hangzhou Tigermed Consulting Co., Ltd, which was founded in 2002.
He held the position of Chief Executive Officer & General Manager from 2009 to 2010.
Currently, he holds multiple positions as Chairman at Hunan Tiger-Xiangya R&D Co., Ltd., Executive Director at Macrostat (China) Clinical Research Co., Ltd., Executive Director at Shanghai Tigermed Consulting Co., Ltd., Executive Director & General Manager at Jiaxing-tigermed Data Management Co., Ltd., and Executive Director at Guangzhou Tigermed Research Institution Co., Ltd.
In the past, he held the position of Chairman & General Manager at Hangzhou Tigermed Consulting Co., Ltd., Medical Director at Shanghai Roche Pharmaceutical Co., Ltd., Director at Coland Pharmaceutical Co., Ltd., Director at Coland Holdings Ltd., Director-Supervisory Board at Shanghai Guo Chuang Pharmaceutical Co., Ltd., and Director at Hongkong Tigermed Co., Ltd.
Dr. Ye received a doctorate from the University of Oxford and an MBA from Peking University.
Xiao Ping Ye active positions
Companies | Position | Start |
---|---|---|
Shanghai Tigermed Consulting Co., Ltd. | Director/Board Member | - |
Hunan Tiger-Xiangya R&D Co., Ltd. | Chairman | - |
Macrostat (China) Clinical Research Co., Ltd. | Director/Board Member | - |
Jiaxing-tigermed Data Management Co., Ltd. | President | - |
Guangzhou Tigermed Research Institution Co., Ltd. | Director/Board Member | - |
Former positions of Xiao Ping Ye
Companies | Position | End |
---|---|---|
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Director/Board Member | - |
COLAND HOLDINGS LIMITED | Director/Board Member | - |
Hongkong Tigermed Co., Ltd.
Hongkong Tigermed Co., Ltd. Financial ConglomeratesFinance Hongkong Tigermed Co., Ltd. operates as an investment holding company. It was founded on September 14, 2011 and is headquartered in Hong Kong. | Director/Board Member | - |
HANGZHOU TIGERMED CONSULTING CO., LTD | Chairman | - |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Xiao Ping Ye
University of Oxford | Doctorate Degree |
Peking University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HANGZHOU TIGERMED CONSULTING CO., LTD | Commercial Services |
Private companies | 11 |
---|---|
Hangzhou Tigermed Consulting Co., Ltd
Hangzhou Tigermed Consulting Co., Ltd Medical/Nursing ServicesHealth Services Tigermed Consulting Co., Ltd. is a Contract Research Organization (CRO) in China that provides regulatory service, Phase I-IV clinical trials, data management & biostatistics, medical translations and GCP training services for healthcare products. The company was founded in 2002 and is headquartered in Shanghai, CN. | Health Services |
Shanghai Roche Pharmaceutical Co., Ltd.
Shanghai Roche Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche (China) Co. Ltd., Shanghai Roche Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
Coland Pharmaceutical Co., Ltd.
Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Health Technology |
Coland Holdings Ltd.
Coland Holdings Ltd. Pharmaceuticals: MajorHealth Technology Coland Holdings Ltd. engages in the research, development, and sale of generic and traditional Chinese medicine, biochemical drugs, and medical equipment. It focuses on the treatment of hepatobiliary, respiratory system, tumor, and cardiovascular problems. The company was founded on March 23, 2010 and is headquartered in Shanghai, China. | Health Technology |
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Health Technology |
Macrostat (China) Clinical Research Co., Ltd. | |
Shanghai Tigermed Consulting Co., Ltd. | |
Hunan Tiger-Xiangya R&D Co., Ltd. | |
Jiaxing-tigermed Data Management Co., Ltd. | |
Guangzhou Tigermed Research Institution Co., Ltd. | |
Hongkong Tigermed Co., Ltd.
Hongkong Tigermed Co., Ltd. Financial ConglomeratesFinance Hongkong Tigermed Co., Ltd. operates as an investment holding company. It was founded on September 14, 2011 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Xiao Ping Ye